Framing the onset of lung cancer biographically: Narratives of continuity and disruption

Psycho-Oncology

Volumn 16, Issue 5, 2007, Pages 466-473

  Leveälahti, Helena ^a,b   Tishelman, Carol ^a,b   Öhlén, Joakim ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Stockholms Sjukhem Foundation   (Sweden)

Author keywords

Diagnosis; Lung cancer; Oncology; Qualitative research; Symptoms

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; AUDIO RECORDING; CANCER SURVIVAL; CONCEPT FORMATION; DISEASE ASSOCIATION; FEMALE; HUMAN; INOPERABLE CANCER; INTERVIEW; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NARRATIVE; ONSET AGE; QUALITATIVE ANALYSIS; SEMI STRUCTURED INTERVIEW; SYMPTOMATOLOGY;

AGED; AGED, 80 AND OVER; DENIAL (PSYCHOLOGY); FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LIFE STYLE; LUNG NEOPLASMS; MALE; MENTAL RECALL; MIDDLE AGED; NEOPLASM STAGING; PATIENT ACCEPTANCE OF HEALTH CARE; RATIONALIZATION; REFERRAL AND CONSULTATION; SICK ROLE; SMOKING CESSATION; TOBACCO SMOKE POLLUTION;

EID: 34249711784     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1080     Document Type: Article

References (47)

1. Alberg A, Samet J. Epidemiology of lung cancer. Chest 2003; 123(1):21S-49S.
2. Fu JB, Kau TY et al. Lung cancer in women: analysis of the national surveillance, epidemiology, and end results database. Chest 2005;127(3):768-777.
3. Sorenson S, Glimelius B et al. A systematic overview of chemotherapy effects in non-small cell lung cancer. Acta Oncol 2001;40(2-3):327-339.
4. Bunn Jr P. Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why? J Clin Oncol 2002; 20(18s):23s-33s.
5. Waters J, O'Brien M. The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence. Br J Cancer 2002;87:481-490.
6. Birring SS, Peake MD. Symptoms and the early diagnosis of lung cancer. Thorax 2005;60(4):268-269.
7. Koyi H, Hillerdal G et al. Patient's and doctors' delays in the diagnosis of chest tumors. Lung Cancer 2002;35(1):53-57.
8. Buccheri G, Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J 2004;24(6): 898-904.
9. Beckles MA, Spiro SG et al. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003;123 (1 Suppl.):97S-104S.
10. Cooley ME, Short TH et al. Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psycho-Oncology 2003;12(7): 694-708.
11. Sarna L, Evangelista L et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest 2004;125(2):439-445.
12. Muers MF, Holmes WF et al. Issues at the interface between primary and secondary care in the management of common respiratory disease. 1. The challenge of improving the delivery of lung cancer care. Thorax 1999;54(6):540-543.
13. Krishnasamy M, Wilkie E et al. Lung cancer health care needs assessment: patients' and informal carers' responses to a national mail questionnaire survey. Palliative Med 2001;15(3):213-227.
14. Myrdal G, Lambe M et al. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 2004;59(1):45-49.
15. Ozlu T, Bulbul Y et al. Time course from first symptom to the treatment of lung cancer in the Eastern Black Sea Region of Turkey. Med Prin Pract 2004;13(4): 211-214.
16. Corner J, Hopkinson J et al. Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis. Thorax 2005; 60(4):314-319.
17. Haas M. Contemporary Issues in Lung Cancer: A Nursing Perspective. Jones and Bartlett Pub.: Sudbury, MA, 2003.
18. Moore RJ, Chamberlain RM et al. A voice that wraps around the body-communication problems in the advanced stages of non-small cell lung cancer. Yale J Biol Med 2001;74(6):367-382.
19. Chapple A, Ziebland S et al. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study. Br Med J 2004; 328(7454): 1470.
20. Street AF. Ask your doctor: the construction of smoking in advertising posters produced in 1946 and 2004. Nurs Inquiry 2004; 11(4):226-237.
21. Greenhalgh T, Hurwitz B. Why study narrative? In Narrative Based Medicine. Dialogue and Discourse in Clinical Practice, Greenhalgh T, Hurwitz B (eds). BMJ Books: London, 1998.
22. Mattingly C. Healing Dramas and Clinical Plots. The Narrative Structure of Experience. Cambridge University Press: Cambridge, 1998.
23. Hogarth S, Marks L. The golden narrative in British medicine. In Narrative Based Medicine. Dialogue and Discourse in Clinical Practice, Greenhalgh T, Hurwitz B (eds). BMJ Books: London, 1998.
24. Frank AW. Reclaiming an orphan genre: the first-person narrative of illness. Lit Med 1994;13(1): 1-21.
25. Riessman CK. Narrative Analysis. Sage: Newbury Park, 1993.
26. Ricoeur P. The narrative function. In Hermeneutics and the Human Sciences: Essays on Language, Action and Interpretation, Thompson JB (ed). Cambridge University Press: Cambridge, 1981;274-296.
27. Tishelman C, Degner L et al. Symptoms in patients with lung carcinoma: distinguishing distress from intensity. Cancer 2005; 104(9):2013-2021.
28. Flick U. An Introduction to Qualitative Research. Sage: London, 2002.
29. Labov W. Speech actions and reactions in personal narrative. In Analyzing Discourse: Text and Talk, Tannen D (ed). Georgetown University Press: Washington, DC, 1982;219-247.
30. Riessman CK. Analysis of personal narratives. In Handbook of Interviewing, Gubrium JF, Holstein JA (eds). Sage: Newbury Park, CA, 2001;695-710.
31. Bury M. Chronic illness as biographical disruption. Sociol Health Ill 1982;4(2):167-182.
32. Faircloth CA, Boylstein C et al. Sudden illness and biographical flow in narratives of stroke recovery. Sociol Health Ill 2004; 26(2):242-261.
33. Salander P. Bad news from the patient's perspective: an analysis of the written narratives of newly diagnosed cancer patients. Soc Sci Med 2002;55(5): 721-732.
34. Sarna L, Brown JK et al. Quality of life and meaning of illness of women with lung cancer. Oncol Nurs Forum 2005;32:E9-E19.
35. Rajaram SS, Hill J et al. A biographical disruption: the case of an abnormal pap smear. Health Care Women Int 1997; 18(6):521-531.
36. Gurevich M, Bishop S et al. (Dis)embodying gender and sexuality in testicular cancer. Soc Sci Med 2004;58(9): 1597-1607.
37. Sanders C, Donovan J et al. The significance and consequences of having painful and disabled joints in older age: co-existing accounts of normal and disrupted biographies. Sociol Health Ill 2002; 24(2): 227-253.
38. Williams S. Bodily dys-order: chronic illness as biographical disruption? Medicine and the Body. Sage: London, 2003;251 (Chapter 5).
39. Tritter JQ, Calnan M. Cancer as a chronic illness? Reconsidering categorization and exploring experience. Eur J Cancer Care (Engl) 2002;11(3):161-165.
40. Tishelman C, Sachs L. The diagnostic process and the boundaries of normality. Qual Health Res 1998;8(1): 48-60.
41. Corner J, Hopkinson J et al. Experience of health changes and reasons for delay in seeking care: a UK study of the months prior to the diagnosis of lung cancer. Soc Sci Med 2006;62(6):1381-1391.
42. Mor V, Masterson-Allen S et al. Pre-diagnostic symptom recognition and help seeking among cancer patients. J Commun Health 1990; 15(4): 253-266.
43. Salander P, Bergenheim AT et al. Pathways from symptoms to medical care: a descriptive study of symptom development and obstacles to early diagnosis in brain tumour patients. Fam Pract 1999;16(2): 143-148.
44. Bury M. Illness narratives: fact or fiction? Sociol Health Ill 2001;23(3):263-285.
45. Frank AW. The Wounded Storyteller: Body, Illness, and Ethics. The University of Chicago Press: Chicago, 1995.
46. Carricaburu D, Pierret J. From biographical disruption to biographical reinforcement - the case of HIV-positive men. Sociol Health Ill 1995;17(1):65-88.
47. Carlsson C. Advocates and Voices: Swedish Patient Associations, Their Importance to Individuals with Cancer and Collaboration with Health Care. Department of Oncology, University of Lund: Lund, 2005.